CRP and metabolic dysfunction-associated steatotic liver disease: For instance, in a case–control study on subclinical atherosclerosis and arterial stiffness in MASLD patients conducted by Tahabet S et al. in the Journal of Vascular Medicine in May 2021 (24), it was pointed out that the CRP level of MASLD patients was significantly increased, and this increase was closely related to the degree of liver steatosis.